Test strip for collecting of blood sugar daily profiles and process for its preparation

• US 4,748,114 A
• Filed: 02/19/1985
• Issued: 05/31/1988
• Est. Priority Date: 04/09/1984
• Status: Expired due to Fees

• Current Assignee: VEB Arzneimittelwerk Drsden
• Original Assignee: Veb Arzneimittelwrk Dresden
• Inventors: Mohr, Peter, Kallies, Karl-Heinz, Kallies, Gert, Thiele, Hans-Jurgen, Plaschnick, Dieter, Pahlitzsch, Conrad J., Kretschmer, Lothar
• Primary Examiner(s): Marantz, Sidney
• Assistant Examiner(s): NOT, DEFINED
• Application Number:
  US06/703,234
• Time in Patent Office: 1,197 Days
• Field of Search: 435/14, 435/28, 435/25, 435/190, 435/192, 435/177, 435/178, 435/805, 435/288, 435/291, 435/188, 422/56, 422/57, 427/2
• US Class Current: 435/14
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: G01N 33/523 the element being adapted for a specific analyte
• CPC Class Codes: Y10S 435/805 Test papers

Abstract

The invention relates to a test strip for taking of daily blood sugar profiles, and also for glucose determination in urine for determining the individual kidney threshold of a diabetic as a daily profile, which finds use in glucose diagnosis.

The objective of the invention is to stabilize the test strip in its function and to adapt it to customary measuring instruments, and this is achieved by attaching a film reaction membrane to a carrier, wherein the membrane was post treated with a complexing agent and an acyclic hydroxyamine or amino derivative.

Claims

1. A test strip for receiving blood sugar daily profiles, comprising a carrier, a film forming membrane, and an enzyme indicator reaction layer disposed on said membrane, said reaction layer containing glucose oxidase, peroxidase, and o-tolidine, said reaction layer being treated with from about 0.01 to about 0.1 mole of a chelating agent and with from about 0.01 to about 1 mole of choline, amino-trihydroxymethylmethane, collidine, quinoline or quinoazine.

2. The test strip according to claim 1, characterized in that the film membrane is made from a plastic membrane that is insoluble in water.

3. The test strip according to claim 2, characterized in that the plastic membrane is colorless, white or colored.

4. The test strip according to claim 1, characterized in that the surface of the film membrane is entirely or only partly coated with the reaction layer.

5. The test strip according to claim 1, characterized in that the carrier is made from white plastic membrane.

6. The test strip according to claim 1, characterized in that the carrier is white filter paper.

7. The test strip according to claim 1, characterized in that the film reaction membrane is connected to the carrier by sealing or by adhesion.

8. The test strip according to claim 1, characterized in that the film reaction membrane is partially or totally connected to the carrier.

9. The test strip according to claim 1, characterized in that the film reaction membrane is connected to the carrier with a polyvinyl chloride polyester or cellulose acetate foil having a layer of adhesive thereon which does not affect the measurement function.

10. The test strip according to claim 1, wherein the reaction layer of the film reaction membrane which is facing the carrier, is connected to filter paper.

11. The test strip of claim 1, wherein the membrane further contains a softener, crosslinking agent, and a dye coupler, or a softener and crosslinking agent, or a dye coupler.

12. Test strip according to claim 1, wherein the carrier substrate is a white cardboard.

13. A method for determining glucose in urine specimen, comprising applying the urine specimen of a diabetic to the test strip of claim 1, and observing the result.

14. A process for preparing a test strip for receiving blood sugar daily profiles, comprising a carrier, a film forming membrane, and an enzyme indicator reaction layer disposed on said film forming membrane, said enzyme indicator reaction layer containing glucose oxidase, peroxidase, and o-tolidine, the process comprising the steps of:

(a) applying the film forming membrane to the enzyme indicator reaction layer,

(b) swelling the indicator reaction layer with from about 0.01 to about 0.1 mole of a chelating agent and from 0.01 to about 1 mole of choline, amino-trishydroxymethylmethane, collidine, quinoline, or piperazin,

(c) treating the reaction layer with additional amounts of said chelating agent and choline, amino-trishydroxymethylmethane, collidine, quinoline or piperazin, and

(d) applying the layered film forming membrane to the carrier.

15. A process according to claim 14, wherein the complexing agent is permitted to act for a period of 5 to 30 seconds.

16. A process according to claim 14, wherein nitriloacetic acid is used as the complexing agent.

17. A process according to claim 14, wherein EDTA is used as the complexing agent.

18. A process according to claim 14, wherein the choline, amino-trishydroxymethylmethane, collidine, quinoline, or piperazin is used in a 0.02 to 0.5 molar concentration.

19. A process according to claim 14, wherein the choline, amino-trishydroxymethylmethane, collidine, quinoline, or piperazin is permitted to act for a period of 60 to 120 seconds.

20. A process according to claim 14, wherein the film reaction membrane is simultaneously treated with a complexing agent and an choline, amino-trishydroxymethylmethane, collidine, quinoline, or piperazin.

21. A process according to claim 14, wherein the water absorption capacity of the film reaction membrane is increased by 10 to 25% per minute as a result of treating it with the chelating agent and choline, amino-trishydroxymethylmethane, collidine, quinoline, or piperazin.

22. A process according to claim 14, wherein the complexing agent is permitted to act for a period of about 5 to about 10 seconds.

23. The process of claim 14, wherein the membrane further contains a softener, crosslinking agent, and a dye coupler, or a softener and crosslinking agent, or a dye coupler.